Zura Bio Limited
ZURAHealthcare|Biotechnology|US
$4.09
+0.37 (+9.95%)
DCF Value
$1.15
Tangible Book / Share
$1.39
Cash / Share
$1.47
Ownership Breakdown
47.3%
Float
96.3M
Shares Outstanding
45.6M
Float Shares
Major Holders (36)
Combined: 299.4%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Access Industries Holdings LLC | Other | 18.20% | 19,699,071 | Mar 2, 2026 | 13D/G |
| Len Blavatnik | Individual | 18.20% | 19,699,071 | Mar 2, 2026 | 13D/G |
| Access Industries Management, LLC | Other | 18.20% | 19,699,071 | Mar 2, 2026 | 13D/G |
| AI Biotechnology LLC | Other | 18.20% | 19,699,071 | Mar 2, 2026 | 13D/G |
| Athanor Capital | Corporation | 15.70% | 11,581,402 | Jan 27, 2026 | 13D/G |
| UGS Capital LLC | Other | 15.70% | 11,581,402 | Jan 27, 2026 | 13D/G |
| Koh, Bong | Individual | 9.99% | 6,853,600 | Nov 14, 2024 | 13D/G |
| Shah, Nimish | Individual | 9.99% | 6,853,600 | Nov 14, 2024 | 13D/G |
| VHCP Co-Investment Holdings III, LLC | Other | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| Bong Y. Koh | Individual | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| Nimish Shah | Individual | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| VHCP Management EG, LLC | Other | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| VHCP Management III, LLC | Other | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| Venrock Healthcare Capital Partners EG, L.P. | Partnership | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| Venrock Healthcare Capital Partners III, L.P. | Partnership | 9.90% | 9,816,384 | May 15, 2026 | 13D/G |
| Suvretta Capital Management, LLC | IA, OO | 9.90% | 9,524,263 | May 12, 2026 | 13D/G |
| Aaron Cowen | HC, IN | 9.90% | 9,524,263 | May 12, 2026 | 13D/G |
| Bong Y Koh | Individual | 9.90% | 7,031,271 | May 15, 2025 | 13D/G |
| Averill Master Fund, Ltd. | Corporation | 8.80% | 8,372,230 | May 12, 2026 | 13D/G |
| Averill Master Fund, LTD | Corporation | 7.70% | 4,995,444 | Feb 13, 2026 | 13D/G |
| Jpmorgan Chase & Co. | Holding company | 7.50% | 4,672,416 | Jul 16, 2025 | 13D/G |
| Rajeev Shah | HC, IN | 4.90% | 3,217,503 | Feb 14, 2025 | 13D/G |
| RA Capital Healthcare Fund, L.P. | Partnership | 4.90% | 3,217,503 | Feb 14, 2025 | 13D/G |
| RA Capital Management, L.P. | IA, PN | 4.90% | 3,217,503 | Feb 14, 2025 | 13D/G |
| Peter Kolchinsky | HC, IN | 4.90% | 3,217,503 | Feb 14, 2025 | 13D/G |
| Jpmorgan Chase & Co | Holding company | 4.70% | 4,471,316 | May 6, 2026 | 13D/G |
| Pfizer Inc. | Corporation | 4.60% | 2,970,022 | Feb 12, 2025 | 13D/G |
| Ms. Lillian Nordahl | HC, IN | 4.44% | 4,215,930 | May 15, 2026 | 13D/G |
| Dr. Jeffrey R. Jay, M.D. | HC, IN | 4.44% | 4,215,930 | May 15, 2026 | 13D/G |
| Great Point Partners, LLC | IA, OO | 4.44% | 4,215,930 | May 15, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | Other | 3.18% | 2,077,251 | Feb 14, 2025 | 13D/G |
| Daniel Schneeberger | Individual | 3.18% | 2,077,251 | Feb 14, 2025 | 13D/G |
| ADAR1 Capital Management GP, LLC | Other | 2.42% | 1,578,787 | Feb 14, 2025 | 13D/G |
| Deep Track Biotechnology Master Fund, Ltd. | Corporation | 0.40% | 259,014 | Nov 14, 2025 | 13D/G |
| David Kroin | HC, IN | 0.40% | 259,014 | Nov 14, 2025 | 13D/G |
| Deep Track Capital, LP | IA, OO | 0.40% | 259,014 | Nov 14, 2025 | 13D/G |
Insider Trades (93)
Last 4 quarters: 7,985,054 acquired · 0 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mathew Marlyn Teresa | VP, Principal Acctg. Officer | Apr 17, 2026 | OTHER | 0 | — | — | Form 4 |
| Mathew Marlyn Teresa | VP, Principal Acctg. Officer | Apr 17, 2026 | OTHER | 11,133 | — | — | Form 4 |
| Mathew Marlyn Teresa | VP, Principal Acctg. Officer | Apr 17, 2026 | OTHER | 90,000 | $3.38 | $304.2K | Form 4 |
| Mathew Marlyn Teresa | VP, Principal Acctg. Officer | Apr 17, 2026 | OTHER | 81,150 | $1.20 | $97.4K | Form 4 |
| Mathew Marlyn Teresa | VP, Principal Acctg. Officer | Apr 17, 2026 | OTHER | 66,220 | $6.03 | $399.3K | Form 4 |
| Jarrett Jennifer | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Thiara Parvinder | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Schoch Steven J | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Nirula Ajay | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Munshi Amit | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Eisner Mark | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Becker Daniel J. | director | Jun 17, 2026 | AWARD | 51,000 | $3.62 | $184.6K | Form 4 |
| Whale Gary | Chief Technology Officer | Apr 1, 2026 | AWARD | 263,000 | $6.03 | $1.6M | Form 4 |
| Nistala Kiran | See Remarks | Apr 1, 2026 | AWARD | 340,900 | $6.03 | $2.1M | Form 4 |
| Hyllengren Eric J | Chief Financial Officer | Apr 1, 2026 | AWARD | 340,900 | $6.03 | $2.1M | Form 4 |
| Davis Kim | Chief Legal Officer | Apr 1, 2026 | AWARD | 425,700 | $6.03 | $2.6M | Form 4 |
| Kulkarni Sandeep Chidambar | director, officer: Chief Executive Officer | Apr 1, 2026 | AWARD | 894,000 | $6.03 | $5.4M | Form 4 |
| Nirula Ajay | director | Feb 21, 2026 | AWARD | 37,812 | $6.53 | $246.9K | Form 4 |
| Nirula Ajay | Feb 21, 2026 | OTHER | 0 | — | — | Form 4 | |
| AI Biotechnology LLC | 10 percent owner | Feb 26, 2026 | BUY | 2,000,000 | $6.25 | $12.5M | Form 4 |
| Eisner Mark | director | Feb 21, 2026 | AWARD | 37,812 | $6.53 | $246.9K | Form 4 |
| Eisner Mark | Feb 21, 2026 | OTHER | 0 | — | — | Form 4 | |
| Thiara Parvinder | director | Jan 23, 2026 | AWARD | 38,823 | $6.36 | $246.9K | Form 4 |
| Thiara Parvinder | director | Jan 23, 2026 | OTHER | 117,000 | $2.76 | $322.9K | Form 4 |
| Thiara Parvinder | director | Jan 23, 2026 | OTHER | 48,149 | $3.98 | $191.6K | Form 4 |
| Kulkarni Sandeep Chidambar | director, officer: Chief Executive Officer | Jan 21, 2026 | AWARD | 2,934,107 | $6.32 | $18.5M | Form 4 |
| Athanor Capital | 10 percent owner | Dec 29, 2025 | OTHER | 0 | — | — | Form 4 |
| Hyllengren Eric J | Chief Financial Officer | Jul 15, 2025 | AWARD | 672,000 | $1.30 | $873.6K | Form 4 |
| Hyllengren Eric J | Jul 7, 2025 | OTHER | 0 | — | — | Form 4 | |
| Becker Daniel J. | director | May 29, 2025 | AWARD | 51,000 | $1.02 | $52.0K | Form 4 |
| Becker Daniel J. | May 21, 2025 | OTHER | 0 | — | — | Form 4 | |
| AI Biotechnology LLC | 10 percent owner | May 21, 2025 | OTHER | 0 | — | — | Form 4 |
| AI Biotechnology LLC | 10 percent owner | May 21, 2025 | OTHER | 13,146,346 | $0.00 | $13.1K | Form 4 |
| Ploos van Amstel Arnout | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Sidhu Someit | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Munshi Amit | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Kulkarni Sandeep Chidambar | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Schoch Steven J | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Graham Neil Murray Hamilton | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Jarrett Jennifer | director | May 21, 2025 | AWARD | 51,000 | $1.03 | $52.5K | Form 4 |
| Badial Verender S. | Chief Financial Officer | May 8, 2025 | AWARD | 303,100 | $1.26 | $381.9K | Form 4 |
| Whale Gary | Chief Technology Officer | Feb 27, 2025 | AWARD | 302,000 | $1.20 | $362.4K | Form 4 |
| Nistala Kiran | See Remarks | Feb 27, 2025 | AWARD | 341,700 | $1.20 | $410.0K | Form 4 |
| Lisicki Robert | director, officer: Chief Executive Officer | Feb 27, 2025 | AWARD | 1,153,000 | $1.20 | $1.4M | Form 4 |
| Davis Kim | Chief Legal Officer | Feb 27, 2025 | AWARD | 488,800 | $1.20 | $586.6K | Form 4 |
| Sidhu Someit | director | Aug 24, 2024 | AWARD | 721,971 | — | — | Form 4 |
| Sidhu Someit | director | Sep 22, 2023 | DISPOSED | 200,484 | — | — | Form 4 |
| Sidhu Someit | director | Dec 31, 2024 | OTHER | 0 | — | — | Form 4 |
| Sidhu Someit | director | Aug 24, 2024 | AWARD | 835,110 | — | — | Form 4 |
| Sidhu Someit | director | Sep 4, 2024 | DISPOSED | 593,055 | — | — | Form 4 |
| Sidhu Someit | director | Sep 28, 2023 | J | 656,573 | $11.50 | $7.6M | Form 4 |
| Sidhu Someit | director | Oct 30, 2023 | BUY | 2,480,000 | $11.50 | $28.5M | Form 4 |
| Sidhu Someit | director | Sep 28, 2023 | DISPOSED | 1,464,617 | $11.50 | $16.8M | Form 4 |
| Sidhu Someit | director | Aug 23, 2024 | DISPOSED | 2,406,573 | $11.50 | $27.7M | Form 4 |
| Badial Verender S. | Chief Financial Officer | Sep 28, 2023 | J | 355,880 | — | — | Form 4 |
| Badial Verender S. | Chief Financial Officer | Aug 23, 2024 | AWARD | 126,155 | — | — | Form 4 |
| Badial Verender S. | Chief Financial Officer | Aug 23, 2024 | DISPOSED | 420,519 | $11.50 | $4.8M | Form 4 |
| Badial Verender S. | Chief Financial Officer | Sep 28, 2023 | J | 420,519 | $11.50 | $4.8M | Form 4 |
| Davis Kim | Chief Legal Officer | Sep 16, 2024 | AWARD | 1,000 | — | — | Form 4 |
| Davis Kim | Chief Legal Officer | Oct 1, 2023 | AWARD | 500 | — | — | Form 4 |
| Jarrett Jennifer | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Graham Neil Murray Hamilton | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Ploos van Amstel Arnout | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Schoch Steven J | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Kulkarni Sandeep Chidambar | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Munshi Amit | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Thiara Parvinder | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Sidhu Someit | director | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Lisicki Robert | director, officer: Chief Executive Officer | Dec 9, 2024 | AWARD | 117,000 | $2.76 | $322.9K | Form 4 |
| Thiara Parvinder | director | Nov 25, 2024 | SELL | 1,001,633 | $2.73 | $2.7M | Form 4 |
| Thiara Parvinder | director | Sep 11, 2024 | SELL | 3,800,000 | $2.70 | $10.3M | Form 4 |
| Nistala Kiran | See Remarks | Apr 22, 2024 | AWARD | 3,195 | $3.13 | $10.0K | Form 4 |
| Sidhu Someit | director | Sep 4, 2024 | SELL | 51,728 | $3.87 | $200.2K | Form 4 |
| Sidhu Someit | director | Apr 22, 2024 | AWARD | 1,186,901 | $3.13 | $3.7M | Form 4 |
| Munshi Amit | director | Apr 22, 2024 | AWARD | 159,744 | $3.13 | $500.0K | Form 4 |
| Howell Michael | See Remarks | Apr 22, 2024 | AWARD | 7,987 | $3.13 | $25.0K | Form 4 |
| Howell Michael | See Remarks | May 18, 2024 | TAX W/H | 9,860 | $6.05 | $59.7K | Form 4 |
| Howell Michael | See Remarks | Jun 18, 2024 | AWARD | 295,000 | $3.38 | $997.1K | Form 4 |
| Whale Gary | Chief Technology Officer | Jun 18, 2024 | AWARD | 280,000 | $3.38 | $946.4K | Form 4 |
| Davis Kim | Chief Legal Officer | Jun 18, 2024 | AWARD | 420,000 | $3.38 | $1.4M | Form 4 |
| Badial Verender S. | Chief Financial Officer | Jun 18, 2024 | AWARD | 420,000 | $3.38 | $1.4M | Form 4 |
| Lisicki Robert | Chief Executive Officer | Jun 18, 2024 | AWARD | 1,050,000 | $3.38 | $3.5M | Form 4 |
| Nistala Kiran | See Remarks | Jun 18, 2024 | AWARD | 285,000 | $3.38 | $963.3K | Form 4 |
| Ploos van Amstel Arnout | director | May 17, 2024 | BUY | 80,000 | $6.20 | $496.0K | Form 4 |
| Howell Michael | See Remarks | Apr 22, 2024 | BUY | 7,987 | $3.13 | $25.0K | Form 4 |
| Nistala Kiran | Executive Vice President | Apr 22, 2024 | BUY | 3,195 | $3.13 | $10.0K | Form 4 |
| Munshi Amit | director | Apr 22, 2024 | BUY | 159,744 | $3.13 | $500.0K | Form 4 |
| Sidhu Someit | director | Apr 22, 2024 | BUY | 1,186,901 | $3.13 | $3.7M | Form 4 |
| Lisicki Robert | See Remarks | Jan 24, 2024 | AWARD | 1,000,000 | $3.98 | $4.0M | Form 4 |
| Ploos van Amstel Arnout | director | Jan 24, 2024 | AWARD | 48,149 | $3.98 | $191.6K | Form 4 |
| Thiara Parvinder | director, 10 percent owner: | Jan 24, 2024 | AWARD | 48,149 | $3.98 | $191.6K | Form 4 |
| Nistala Kiran | See Remarks | Jan 24, 2024 | AWARD | 350,000 | $3.98 | $1.4M | Form 4 |
| Sidhu Someit | director, 10 percent owner, officer: Chief Executive Officer | Mar 20, 2023 | J | 2,337,630 | — | — | Form 4 |